title: Shortening treatment for tuberculosis--to basics.
authors.affiliation: From the Molecular Mycobacteriology Research Unit, Institute of Infectious Disease and Molecular Medicine, and Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa.
authors.forename: Digby F
authors.initials: DF
authors.lastname: Warner
authors.forename: Valerie
authors.initials: V
authors.lastname: Mizrahi
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D005260:Female; D024841:Fluoroquinolones / Q000008:administration & dosage* / Q000627:therapeutic use*; D000077734:Gatifloxacin; D006801:Humans; D008297:Male; D000077266:Moxifloxacin; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D012293:Rifampin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D000077266:Moxifloxacin; D012293:Rifampin; C018421:rifapentine